Why Wall Street and Jim Cramer Think Danaher Stock Is 'Ready to Play'
Danaher is finally turning the corner. CNBC's Jim Cramer sees it. Wall Street does it too. Life sciences stocks are…
Agilent Technologies Inc.
Jim Cramer has faith in Danaher's turnaround as life sciences come back to life
Life sciences stocks are experiencing a resurgence, and that's good news for Danaher. Connecting the dots with better times ahead…
Life sciences are under pressure due to possible NIH funds cuts
A recent Trump administration movement to substantially reduce the funds of the National Health Institutes for research institutions throughout the…
Strategas sees healthcare outperforming in 2025
The healthcare sector is poised to see a rebound and lead the market this year, according to analysts at Strategas,…
Masimo activist Politan reveals letter and proxy fight plan
Masimo founder and CEO Joe Kiani addresses a press conference in Bengaluru on January 2, 2017. Manjunath Kiran | AFP…